Table 7.

Utility of biomarkers in predicting transplant-free survival

Biomarker	3-mo survival	6-mo survival
(μmol/L)	AUC (95%CI)	AUC (95%CI)
MELD	0.82 (0.69, 0.95)	0.77 (0.62, 0.92)
Tyrosine	0.91 (0.74, 1.0)	0.89 (0.74, 1.0)
Phenylalanine	0.77 (0.56, 0.97)	0.79 (0.61, 0.98)
Carnitine	0.73 (0.53, 0.93)	0.74 (0.56, 0.93)
ADMA	0.72 (0.49, 0.96)	0.70 (0.48, 0.92)
MMA	0.71 (0.47, 0.94)	0.70 (0.49, 0.91)

AUC: Area under receiver operating characteristics curve; MELD: Model for end-stage liver disease; ADMA: Asymmetric dimethylarginine; MMA: Monomethylarginine.